Friday, March 12, 2010 - 6:38AM EST

Review Articles

21. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Author
Singh S; Loke YK; Furberg CD; Singh S; Loke YK; Furberg CD; Singh S; Loke YK; Furberg CD;
Institution
Department of Medicine, One Medical Center Blvd, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. sosingh@wfubmc.edu
Journal
JAMA. 2008 Sep 24;300(12):1439-50.
Abstract URL
Click here to view abstract

22. Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.

Author
Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G; Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G; Puhan MA; Vollenweider D; Steurer J; Bossuyt PM; Ter Riet G;
Institution
Horten Centre for Patient-oriented Research and Knowledge Transfer, University of Zurich, Switzerland. milo.puhan@usz.ch
Journal
BMC Med. 2008 Oct 10;6:28.
Abstract URL
Click here to view abstract

23. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.

Author
Fromer L; Cooper CB; Fromer L; Cooper CB; Fromer L; Cooper CB;
Institution
Department of Family Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA 90077, USA. mdwelby@aol.com
Journal
Int J Clin Pract. 2008 Aug;62(8):1219-36. Epub 2008 Jun 28.
Abstract URL
Click here to view abstract

24. Novel long-acting bronchodilators for COPD and asthma.

Author
Cazzola M; Matera MG; Cazzola M; Matera MG; Cazzola M; Matera MG;
Institution
Unit of Respiratory Diseases, Department of Internal Medicine, University of Rome Tor Vergata, Rome, Italy. mario.cazzola@uniroma2.it
Journal
Br J Pharmacol. 2008 Oct;155(3):291-9. Epub 2008 Jul 7.
Abstract URL
Click here to view abstract

25. Anti-TNF-alpha therapies in chronic obstructive pulmonary diseases.

Author
Antoniu SA; Mihaltan F; Ulmeanu R; Antoniu SA; Mihaltan F; Ulmeanu R; Antoniu SA; Mihaltan F; Ulmeanu R;
Institution
'Gr.T.Popa' University of Medicine and Pharmacy Iasi, Division of Pulmonary Disease, Pulmonary Disease University Hospital, 30 Dr I Cihac Street, 700115 Iasi, Romania. sabina.antonela.antoniu@pneum.umfiasi.ro
Journal
Expert Opin Investig Drugs. 2008 Aug;17(8):1203-11.
Abstract URL
Click here to view abstract

26. Integrating palliative care in severe chronic obstructive lung disease.

Author
Hardin KA; Meyers F; Louie S; Hardin KA; Meyers F; Louie S; Hardin KA; Meyers F; Louie S;
Institution
Department of Internal Medicine, UCD Health System Pulmonary Rehabilitation Program, University of California, Davis, Sacramento, CA 95817, USA.
Journal
COPD. 2008 Aug;5(4):207-20.
Abstract URL
Click here to view abstract

27. Inhaled corticosteroids in obstructive airway disease.

Author
Phua GC; Macintyre NR; Phua GC; Macintyre NR; Phua GC; Macintyre NR;
Institution
Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University Medical Center, Durham NC 27710, USA.
Journal
Respir Care. 2007 Jul;52(7):852-8.
Abstract URL
Click here to view abstract

28. Preventing chronic obstructive pulmonary disease: what is known and what needs to be done to make a difference to the patient?

Author
Wise RA; Tashkin DP; Wise RA; Tashkin DP; Wise RA; Tashkin DP;
Institution
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. rwise@welchlink.welch.jhu.edu
Journal
Am J Med. 2007 Aug;120(8 Suppl 1):S14-22.
Abstract URL
Click here to view abstract

29. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.

Author
Wise RA; Tashkin DP; Wise RA; Tashkin DP; Wise RA; Tashkin DP;
Institution
Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA. rwise@welchlink.welch.jhu.edu
Journal
Am J Med. 2007 Aug;120(8 Suppl 1):S4-13.
Abstract URL
Click here to view abstract

30. What have we learned from large drug treatment trials in COPD?

Author
Calverley PM; Rennard SI; Calverley PM; Rennard SI; Calverley PM; Rennard SI;
Institution
Division of Infection and Immunity, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. pmacal@liverpool.ac.uk
Journal
Lancet. 2007 Sep 1;370(9589):774-85.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9